CIBC Asset Management
EBS icon

CIBC Asset Management’s Emergent Biosolutions EBS Stock Holding History

CIBC Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,454
Closed -$265K – 1337
2022
Q1 		$265K Hold
6,454
– – ﹤0.01% 1137
2021
Q4 		$281K Buy
+6,454
New +$292K ﹤0.01% 1125
2020
Q3 		– Sell
-2,799
Closed -$221K – 1120
2020
Q2 		$221K Buy
+2,799
New +$209K ﹤0.01% 928

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Asset Management's EBS Position: Q2 2022 in Review

CIBC Asset Management sold out of Emergent Biosolutions (EBS) in Q2 2022, closing a stake of 6,454 shares — an estimated $265K sold.

CIBC Asset Management first reported a position in EBS in Q2 2020 and held it in 3 quarters. The position peaked at $281K in Q4 2021. 232 funds tracked by Wall St. Rank hold EBS as of Q2 2022.

  • CIBC Asset Management reported no remaining Emergent Biosolutions position as of Q2 2022 after selling out during the quarter.
  • CIBC Asset Management sold 6,454 Emergent Biosolutions shares in Q2 2022, an estimated $265K.
  • CIBC Asset Management first reported a position in Emergent Biosolutions in Q2 2020 and held it in 3 quarters.
  • CIBC Asset Management's Emergent Biosolutions position peaked at $281K in Q4 2021.
  • 232 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.